» Articles » PMID: 36397166

Recent Progress in Epigenetics of Obesity

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2022 Nov 18
PMID 36397166
Authors
Affiliations
Soon will be listed here.
Abstract

Nowadays, obesity is one of the largest public health problems worldwide. In the last few decades, there has been a marked increase in the obesity epidemic and its related comorbidities. Worldwide, more than 2.2 billion people (33%) are affected by overweight or obesity (712 million, 10%) and its associated metabolic complications. Although a high heritability of obesity has been estimated, the genetic variants conducted from genetic association studies only partially explain the variation of body mass index. This has led to a growing interest in understanding the potential role of epigenetics as a key regulator of gene-environment interactions on the development of obesity and its associated complications. Rapid advances in epigenetic research methods and reduced costs of epigenome-wide association studies have led to a great expansion of population-based studies. The field of epigenetics and metabolic diseases such as obesity has advanced rapidly in a short period of time. The main epigenetic mechanisms include DNA methylation, histone modifications, microRNA (miRNA)-mediated regulation and so on. DNA methylation is the most investigated epigenetic mechanism. Preliminary evidence from animal and human studies supports the effect of epigenetics on obesity. Studies of epigenome-wide association studies and genome-wide histone modifications from different biological specimens such as blood samples (newborn, children, adolescent, youth, woman, man, twin, race, and meta-analysis), adipose tissues, skeletal muscle cells, placenta, and saliva have reported the differential expression status of multiple genes before and after obesity interventions and have identified multiple candidate genes and biological markers. These findings may improve the understanding of the complex etiology of obesity and its related comorbidities, and help to predict an individual's risk of obesity at a young age and open possibilities for introducing targeted prevention and treatment strategies.

Citing Articles

The Effect of Maternal Diet and Lifestyle on the Risk of Childhood Obesity.

Luszczki E, Wyszynska J, Dymek A, Drozdz D, Gonzalez-Ramos L, Hartgring I Metabolites. 2024; 14(12).

PMID: 39728436 PMC: 11679592. DOI: 10.3390/metabo14120655.


Impact of combined exercise on blood DNA methylation and physical health in older women with obesity.

Dawangpa A, Chitta P, da Silva Rodrigues G, Iadsee N, Noronha N, Nonino C PLoS One. 2024; 19(12):e0315250.

PMID: 39680552 PMC: 11649090. DOI: 10.1371/journal.pone.0315250.


Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?.

Odimegwu C, Uwaezuoke S, Chikani U, Mbanefo N, Adiele K, Nwolisa C Diabetes Metab Syndr Obes. 2024; 17:3557-3576.

PMID: 39323929 PMC: 11423826. DOI: 10.2147/DMSO.S479077.


1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation.

Provvisiero D, Negri M, Amatrudo F, Patalano R, Monto T, de Angelis C Int J Obes (Lond). 2024; 48(12):1793-1802.

PMID: 39256615 PMC: 11584397. DOI: 10.1038/s41366-024-01629-w.


Obesity: exploring its connection to brain function through genetic and genomic perspectives.

Saeed S, Bonnefond A, Froguel P Mol Psychiatry. 2024; 30(2):651-658.

PMID: 39237720 PMC: 11746128. DOI: 10.1038/s41380-024-02737-9.


References
1.
Do W, Gohar J, McCullough L, Galaviz K, Conneely K, Narayan K . Examining the association between adiposity and DNA methylation: A systematic review and meta-analysis. Obes Rev. 2021; 22(10):e13319. DOI: 10.1111/obr.13319. View

2.
Dhana K, Braun K, Nano J, Voortman T, Demerath E, Guan W . An Epigenome-Wide Association Study of Obesity-Related Traits. Am J Epidemiol. 2018; 187(8):1662-1669. PMC: 6070087. DOI: 10.1093/aje/kwy025. View

3.
Lischka J, Schanzer A, Hojreh A, Ba-Ssalamah A, de Gier C, Valent I . Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. Int J Obes (Lond). 2021; 45(8):1763-1772. PMC: 8310785. DOI: 10.1038/s41366-021-00842-1. View

4.
Paciencia I, Cavaleiro Rufo J, Silva D, Martins C, Mendes F, Farraia M . Exposure to indoor endocrine-disrupting chemicals and childhood asthma and obesity. Allergy. 2019; 74(7):1277-1291. DOI: 10.1111/all.13740. View

5.
Wlodarski A, Strycharz J, Wroblewski A, Kasznicki J, Drzewoski J, Sliwinska A . The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. Int J Mol Sci. 2020; 21(18). PMC: 7555602. DOI: 10.3390/ijms21186902. View